FI923308A0 - Foerbaettrade preparat innehaollande dideoxpurinnukleosider foer oral administration. - Google Patents

Foerbaettrade preparat innehaollande dideoxpurinnukleosider foer oral administration.

Info

Publication number
FI923308A0
FI923308A0 FI923308A FI923308A FI923308A0 FI 923308 A0 FI923308 A0 FI 923308A0 FI 923308 A FI923308 A FI 923308A FI 923308 A FI923308 A FI 923308A FI 923308 A0 FI923308 A0 FI 923308A0
Authority
FI
Finland
Prior art keywords
dideoxpurinnukleosider
foerbaettrade
foer
oral administration
reduced mass
Prior art date
Application number
FI923308A
Other languages
English (en)
Other versions
FI923308A (fi
FI105153B (fi
Inventor
Ismat Ullah
Shreeram Narahari Agharkar
Gary James Wiley
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27112590&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI923308(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI923308A0 publication Critical patent/FI923308A0/fi
Publication of FI923308A publication Critical patent/FI923308A/fi
Application granted granted Critical
Publication of FI105153B publication Critical patent/FI105153B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
FI923308A 1991-07-22 1992-07-20 Menetelmä farmaseuttisten, suun kautta annettavien dideoksipuriininukleosidikoostumusten valmistamiseksi FI105153B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73354791A 1991-07-22 1991-07-22
US73354791 1991-07-22
US88220492A 1992-05-13 1992-05-13
US88220492 1992-05-13

Publications (3)

Publication Number Publication Date
FI923308A0 true FI923308A0 (fi) 1992-07-20
FI923308A FI923308A (fi) 1993-01-23
FI105153B FI105153B (fi) 2000-06-30

Family

ID=27112590

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923308A FI105153B (fi) 1991-07-22 1992-07-20 Menetelmä farmaseuttisten, suun kautta annettavien dideoksipuriininukleosidikoostumusten valmistamiseksi

Country Status (23)

Country Link
US (1) US5880106A (fi)
EP (1) EP0524579B1 (fi)
JP (1) JP3038456B2 (fi)
KR (1) KR960011772B1 (fi)
CN (1) CN1042299C (fi)
AT (1) ATE163855T1 (fi)
AU (1) AU657337B2 (fi)
CA (1) CA2074215C (fi)
DE (1) DE69224684T2 (fi)
DK (1) DK0524579T3 (fi)
ES (1) ES2113389T3 (fi)
FI (1) FI105153B (fi)
GR (1) GR3026332T3 (fi)
HU (3) HU9202318D0 (fi)
IE (1) IE922365A1 (fi)
IL (1) IL102519A (fi)
MX (1) MX9204256A (fi)
NO (1) NO300198B1 (fi)
NZ (1) NZ243567A (fi)
PL (1) PL295329A1 (fi)
RU (1) RU2089193C1 (fi)
TW (1) TW211521B (fi)
ZA (1) ZA925484B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA69413C2 (uk) * 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
IL134592A0 (en) * 1998-06-18 2001-04-30 Univ George Washington Compositions comprising camptothecin compounds for the treatment of cancer with reduced side effects
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
EP1311240A1 (en) * 2000-08-14 2003-05-21 Fertin Pharma A/S Method for preparation of chewing gum with customer acceptable taste
US6887926B1 (en) 2001-11-16 2005-05-03 Oatey Co. Bonding compositions for chlorinated polymers and methods of using the same
CN100415211C (zh) * 2003-07-03 2008-09-03 上海现代药物制剂工程研究中心 抗艾滋病药去羟肌苷的肠溶微粒组合物及制备方法
US20080299227A1 (en) * 2007-05-30 2008-12-04 Sunhealth Therapies, Inc. Method for removal of HIV from the gastrointestinal tract and bile of HIV-infected subjects and for the prevention of drug failure and prevention of development of AIDS in HIV-infected subjects
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
SG172363A1 (en) 2008-12-23 2011-07-28 Pharmasset Inc Synthesis of purine nucleosides
CL2009002207A1 (es) 2008-12-23 2011-02-18 Gilead Pharmasset Llc Compuestos derivados de 3-hidroxi-5-(9h-purin-9-il)tetrahidrofuran-2-il, inhibidor de la replicacion de arn viral dependiente de arn; composicion farmaceutica; uso para el tratamiento de hepatitis c.
WO2010075517A2 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Nucleoside analogs
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
UY33310A (es) 2010-03-31 2011-10-31 Pharmasset Inc Sintesis estereoselectiva de activos que contienen fosforo
AP3515A (en) 2010-03-31 2016-01-11 Gilead Pharmasset Llc Nucleoside phosphoramidates
EP2428201A1 (en) 2010-09-08 2012-03-14 Merck Serono S.A. Oral administration of nucleoside monophosphates
JP6069215B2 (ja) 2010-11-30 2017-02-01 ギリアド ファーマセット エルエルシー 化合物
CN102949406B (zh) * 2011-08-31 2014-03-12 天津药物研究院 一种复方艾夫他滨药物组合物及其制备方法和用途
AR089857A1 (es) * 2012-02-02 2014-09-24 Glaxosmithkline Llc Comprimido antiacido para refrescar el aliento
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
CN104069126A (zh) * 2014-07-02 2014-10-01 浙江康乐药业股份有限公司 一种治疗胃酸过多的药物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260596A (en) * 1979-08-13 1981-04-07 Bristol-Myers Company Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
CH674148A5 (fi) * 1986-06-24 1990-05-15 Racz Istvan
WO1988002629A1 (en) * 1986-10-16 1988-04-21 American Health Products Corporation 2',3'-didesoxyadenosine composition
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5026687A (en) * 1990-01-03 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds

Also Published As

Publication number Publication date
IL102519A (en) 1996-01-31
HU211285A9 (en) 1995-11-28
HU220612B1 (hu) 2002-03-28
JP3038456B2 (ja) 2000-05-08
NO300198B1 (no) 1997-04-28
CN1042299C (zh) 1999-03-03
IE922365A1 (en) 1992-11-18
KR930001912A (ko) 1993-02-22
ES2113389T3 (es) 1998-05-01
FI923308A (fi) 1993-01-23
NO922807L (no) 1993-01-25
FI105153B (fi) 2000-06-30
MX9204256A (es) 1993-01-01
DK0524579T3 (da) 1998-04-06
HUT61472A (en) 1993-01-28
CA2074215C (en) 2001-12-18
NO922807D0 (no) 1992-07-16
IL102519A0 (en) 1993-01-14
GR3026332T3 (en) 1998-06-30
AU2039692A (en) 1993-01-28
ATE163855T1 (de) 1998-03-15
RU2089193C1 (ru) 1997-09-10
JPH05194234A (ja) 1993-08-03
TW211521B (fi) 1993-08-21
CA2074215A1 (en) 1993-01-23
CN1068739A (zh) 1993-02-10
US5880106A (en) 1999-03-09
HU9202375D0 (en) 1992-10-28
EP0524579B1 (en) 1998-03-11
ZA925484B (en) 1993-09-13
DE69224684D1 (de) 1998-04-16
PL295329A1 (en) 1993-04-05
NZ243567A (en) 1995-04-27
DE69224684T2 (de) 1998-11-12
HU9202318D0 (en) 1992-10-28
AU657337B2 (en) 1995-03-09
KR960011772B1 (ko) 1996-08-30
EP0524579A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
FI923308A0 (fi) Foerbaettrade preparat innehaollande dideoxpurinnukleosider foer oral administration.
IT1211484B (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
PT90466A (pt) Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina
ATE125155T1 (de) Niedrigdosierte getrocknete pharmazeutische präparate.
DE69331906D1 (de) Granulierte pharmazeutische zusammensetzung
DE69211688D1 (de) Kaubare antacida
GB2282758A (en) Oral morphine-6-glucuronide compositions
ITRM910038A1 (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.
TH13351A (th) สารประกอบ
ATE181828T1 (de) Oral anzuwendendes arzneimittel bestehend aus ibuprofen

Legal Events

Date Code Title Description
MA Patent expired